Fundraising FoxKdT Ventures — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Andes develops a microbial technology that converts atmospheric carbon dioxide into stable soil inorganic carbon, enabling agricultural fields to generate verified carbon credits for emissions reductions.
AgTechCleantechClimate TechImpact & Social GoodAlameda, US
Board seatPhil Grayeski· per SEC Form D
Co-investorsCavallo VenturesLeaps by BayerVoyager Partners
Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.
BiotechDeep TechBoston, US
Wayne Lencer(Founder)Hunter Goble(Founder)inJustin Wolfe(Founder)inWilliam Hunter Goble(Executive Officer, Director)Phil Grayeski(Director)
Board seatPhil Grayeski· per SEC Form D
Co-investorsPear VCPortal InnovationsTau VenturesDigitalis VenturesTAU VenturesXora Innovation Pte Ltd
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsAccelr8Capria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager Partners+3 more
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.
AgTechEnterprise Software
Michael Wilbur(President)in
Co-investorsWilbur-Ellis [Cavallo]Accelr8Builders VCGermin8 VenturesLeaps by Bayer
Modulus Therapeutics was a Seattle biotech spun out of the Allen Institute for AI that used machine learning to engineer immune cells, initially NK cells for cancer, later shifting toward autoimmune cell therapies.
BiotechSeattle, US
Bryce R Daines(Executive Officer, Director)Max C Darnell(Executive Officer, Director)
Co-investorsMadrona Venture Group
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
BoardDavid Zhu(Director)in
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesGaingelsKendall Capital PartnersLifespan Vision Ventures+1 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.